[
    [
        {
            "time": "2023-10-05",
            "original_text": "The Eaton Vance Fund sells Novartis, Pfizer",
            "features": {
                "keywords": [
                    "Eaton Vance Fund",
                    "sells",
                    "Novartis",
                    "Pfizer"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Pharma Stock Roundup: Big Drugmakers Q1 Earnings, Resumption of JNJ US COVID-19 Jabs",
            "features": {
                "keywords": [
                    "Pharma Stock",
                    "Big Drugmakers",
                    "Q1 Earnings",
                    "Resumption",
                    "JNJ",
                    "US",
                    "COVID-19 Jabs"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: Big Drugmakers Q1 Earnings, Resumption of JNJ US COVID-19 Jabs",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Alnylam's (ALNY) Q1 Loss Narrower Than Expected, Revenues Beat",
            "features": {
                "keywords": [
                    "Alnylam",
                    "Q1 Loss",
                    "Narrower",
                    "Expected",
                    "Revenues Beat"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]